ARCT
Price
$6.82
Change
-$0.19 (-2.71%)
Updated
Jun 25 closing price
Capitalization
193.7M
45 days until earnings call
Intraday BUY SELL Signals
QSI
Price
$0.86
Change
+$0.03 (+3.61%)
Updated
Jun 25 closing price
Capitalization
188.69M
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARCT vs QSI

ARCT vs QSI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARCT vs. QSI commentary
Jun 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Buy and QSI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2026
Stock price -- (ARCT: $6.82 vs. QSI: $0.87)
Brand notoriety: ARCT and QSI are both not notable
ARCT represents the Biotechnology, while QSI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ARCT: 84% vs. QSI: 128%
Market capitalization -- ARCT: $193.7M vs. QSI: $188.69M
ARCT [@Biotechnology] is valued at $193.7M. QSI’s [@Medical/Nursing Services] market capitalization is $188.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.87B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $162.41B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileQSI’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • QSI’s FA Score: 0 green, 5 red.
According to our system of comparison, ARCT is a better buy in the long-term than QSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 3 TA indicator(s) are bullish while QSI’s TA Score has 2 bullish TA indicator(s).

  • ARCT’s TA Score: 3 bullish, 4 bearish.
  • QSI’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, ARCT is a better buy in the short-term than QSI.

Price Growth

ARCT (@Biotechnology) experienced а -9.50% price change this week, while QSI (@Medical/Nursing Services) price change was -13.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.73%. For the same industry, the average monthly price growth was +0.72%, and the average quarterly price growth was +1812.66%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.29%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was -14.78%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 10, 2026.

QSI is expected to report earnings on Aug 10, 2026.

Industries' Descriptions

@Biotechnology (+1.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (+0.29% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($194M) and QSI($189M) have the same market capitalization . ARCT YTD gains are higher at: 11.175 vs. QSI (-21.227). ARCT has higher annual earnings (EBITDA): -75M vs. QSI (-91.54M). ARCT has more cash in the bank: 211M vs. QSI (127M). QSI has less debt than ARCT: QSI (3.71M) vs ARCT (24M). ARCT has higher revenues than QSI: ARCT (42.4M) vs QSI (1.85M).
ARCTQSIARCT / QSI
Capitalization194M189M103%
EBITDA-75M-91.54M82%
Gain YTD11.175-21.227-53%
P/E RatioN/AN/A-
Revenue42.4M1.85M2,289%
Total Cash211M127M166%
Total Debt24M3.71M647%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTQSI
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 30 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signal:
Gain/Loss:
QSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMESX35.69N/A
N/A
ClearBridge Appreciation IS
SVIIX10.14N/A
N/A
Virtus Ceredex Large-Cap Value Equity A
ARYMX14.79N/A
N/A
American Century Global Real Estate A
ARMIX20.01N/A
N/A
ARGA Emerging Markets Value Instl
CFMVX27.04N/A
N/A
Commerce MidCap Value

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with ALEC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
-2.78%
ALEC - ARCT
57%
Loosely correlated
+3.07%
AXON - ARCT
49%
Loosely correlated
-2.63%
EDIT - ARCT
43%
Loosely correlated
-2.14%
VCYT - ARCT
42%
Loosely correlated
+3.22%
QSI - ARCT
40%
Loosely correlated
+4.75%
More

QSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, QSI has been loosely correlated with PACB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if QSI jumps, then PACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QSI
1D Price
Change %
QSI100%
+4.75%
PACB - QSI
53%
Loosely correlated
+11.11%
AXON - QSI
49%
Loosely correlated
-2.63%
VCYT - QSI
47%
Loosely correlated
+3.22%
BFLY - QSI
43%
Loosely correlated
+3.22%
NNOX - QSI
42%
Loosely correlated
-43.99%
More